Revolution Medicines (RVMD) News Today $40.47 +0.54 (+1.35%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RVMD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 13.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 102,127 shares of the company's stock after purchasinMay 21 at 4:35 AM | marketbeat.comRevolution Medicines Inc.May 20 at 11:08 AM | wsj.comTang Capital Management LLC Invests $4.37 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)Tang Capital Management LLC purchased a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 100,000May 20 at 6:24 AM | marketbeat.comTema Etfs LLC Invests $1.99 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)Tema Etfs LLC acquired a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 45,522 shares of the company's stock, valued at approximatelMay 20 at 6:16 AM | marketbeat.comMan Group plc Buys 65,567 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Man Group plc increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 25.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 321,673 shares of the company's stock after purchasinMay 20 at 5:04 AM | marketbeat.comDeutsche Bank AG Has $7.76 Million Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)Deutsche Bank AG raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 57.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 177,383 shares of the company's stock after acquiring an additional 64,997 shares during the perMay 20 at 4:10 AM | marketbeat.comPolar Asset Management Partners Inc. Buys 10,900 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Polar Asset Management Partners Inc. boosted its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 34,600 shares of the company's stock after buying aMay 19 at 5:43 AM | marketbeat.comPolar Capital Holdings Plc Invests $32.83 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)Polar Capital Holdings Plc purchased a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 750,665 shares of the company's stock,May 18 at 6:06 AM | marketbeat.comJefferies Financial Group Inc. Buys New Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)Jefferies Financial Group Inc. bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,725 shareMay 18 at 4:34 AM | marketbeat.comResearch Analysts Set Expectations for RVMD Q2 EarningsMay 17, 2025 | americanbankingnews.comMPM Bioimpact LLC Boosts Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)MPM Bioimpact LLC lifted its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 7.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 313,817 shares of the company's stock after purchasing anMay 16, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) is Paradigm Biocapital Advisors LP's 4th Largest PositionParadigm Biocapital Advisors LP increased its position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 23.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,553,111 shares of the company's stock after purchasing an additional 1,239,022 sharMay 16, 2025 | marketbeat.comNextech Invest Ltd. Buys 1,304,347 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Nextech Invest Ltd. raised its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 20.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,601,087 shares of the company's stock after acquiringMay 16, 2025 | marketbeat.comNicholas Investment Partners LP Acquires 22,429 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Nicholas Investment Partners LP boosted its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 36.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 84,729 shares of the company'sMay 16, 2025 | marketbeat.comContrasting Fennec Pharmaceuticals (NASDAQ:FENC) & Revolution Medicines (NASDAQ:RVMD)May 16, 2025 | americanbankingnews.comMaven Securities LTD Acquires Shares of 65,000 Revolution Medicines, Inc. (NASDAQ:RVMD)Maven Securities LTD bought a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 65,000 shares of the company'sMay 15, 2025 | marketbeat.comRevolution Medicines Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating Daraxonrasib in Previously Treated Patients with RAS Mutant Non-Small Cell Lung CancerMay 14, 2025 | globenewswire.comIntegral Health Asset Management LLC Purchases 200,000 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Integral Health Asset Management LLC boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 57.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 550,000 shares of the companMay 14, 2025 | marketbeat.comJ. Goldman & Co LP Invests $1.15 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)J. Goldman & Co LP acquired a new position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 26,335 shares of the company's stock, valMay 14, 2025 | marketbeat.comJanus Henderson Group PLC Grows Position in Revolution Medicines, Inc. (NASDAQ:RVMD)Janus Henderson Group PLC raised its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 54.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,483,999 shares of the companyMay 14, 2025 | marketbeat.comEnsign Peak Advisors Inc Buys 265,389 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Ensign Peak Advisors Inc grew its position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 667.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 305,172 shares of the company's stock after purchasing an additional 265,389May 14, 2025 | marketbeat.comGranahan Investment Management LLC Reduces Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)Granahan Investment Management LLC reduced its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 20.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 119,430 shares of the company's stock after sellMay 13, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires Shares of 248,326 Revolution Medicines, Inc. (NASDAQ:RVMD)BNP Paribas Financial Markets bought a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 248,326 shares of the company's stock,May 13, 2025 | marketbeat.comResearch Analysts Issue Forecasts for RVMD FY2025 EarningsMay 13, 2025 | americanbankingnews.comLeerink Partnrs Has Positive Outlook of RVMD FY2025 EarningsRevolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Stock analysts at Leerink Partnrs increased their FY2025 earnings per share estimates for shares of Revolution Medicines in a report released on Thursday, May 8th. Leerink Partnrs analyst J. Chang now anticipates that the company will earnMay 13, 2025 | marketbeat.comWedbush Expects Reduced Earnings for Revolution MedicinesRevolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Wedbush decreased their Q2 2025 earnings per share estimates for Revolution Medicines in a report released on Thursday, May 8th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings per share of ($1.17) for the quMay 13, 2025 | marketbeat.comFred Alger Management LLC Sells 392,547 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Fred Alger Management LLC reduced its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 72.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 148,126 shares of the company's stock after selling 392,547 shareMay 12, 2025 | marketbeat.comAmeriprise Financial Inc. Acquires 141,426 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Ameriprise Financial Inc. grew its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 9.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,626,848 shares of the company's sMay 12, 2025 | marketbeat.comFarallon Capital Management LLC Boosts Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)Farallon Capital Management LLC lifted its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 17.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,248,692 sharesMay 11, 2025 | marketbeat.comAlgert Global LLC Buys 6,925 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Algert Global LLC increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 17.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 46,973 shares of the comMay 11, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Stake Boosted by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC lifted its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 169.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,000 shares of the company's stock after acquiring aMay 11, 2025 | marketbeat.comRevolution Medicines' (RVMD) "Buy" Rating Reiterated at Needham & Company LLCMay 11, 2025 | americanbankingnews.comRevolution Medicines (NASDAQ:RVMD) Given "Buy" Rating at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $57.00 price objective on shares of Revolution Medicines in a research report on Thursday.May 10, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) is DAFNA Capital Management LLC's 3rd Largest PositionDAFNA Capital Management LLC increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 21.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 631,176 shares of the compaMay 10, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) is Deerfield Management Company L.P. Series C's 7th Largest PositionDeerfield Management Company L.P. Series C raised its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 11.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,258,332 shares of the company's stoMay 10, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 6,698 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Dimensional Fund Advisors LP trimmed its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 1.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 387,775 shares of the company's stock after sellMay 10, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Shares Acquired by Brevan Howard Capital Management LPBrevan Howard Capital Management LP boosted its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 277.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,884 shares of the cMay 9, 2025 | marketbeat.comNorthern Trust Corp Has $67.36 Million Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)Northern Trust Corp increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 17.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,540,078 shares of the company's stock after purchasing an additional 22May 9, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Receives Consensus Rating of "Buy" from BrokeragesRevolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) has earned a consensus rating of "Buy" from the twelve brokerages that are covering the stock, MarketBeat reports. Twelve investment analysts have rated the stock with a buy recommendation. The average 12-month price target among analystsMay 9, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Holdings Cut by Casdin Capital LLCCasdin Capital LLC reduced its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 10.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,699,283 shares of the company'sMay 8, 2025 | marketbeat.comRevolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comRevolution Medicines, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 7, 2025 | seekingalpha.comRevolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate ProgressMay 7, 2025 | globenewswire.comBalyasny Asset Management L.P. Sells 348,957 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Balyasny Asset Management L.P. lessened its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 21.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,302,848 shares of the company's stock after selling 348,957 shares dMay 7, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Buys 24,698 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)The Manufacturers Life Insurance Company boosted its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 11.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 237,539 shares of the companyMay 7, 2025 | marketbeat.comAvidity Partners Management LP Reduces Stock Position in Revolution Medicines, Inc. (NASDAQ:RVMD)Avidity Partners Management LP cut its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 43.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 446,200 shares of the company's stock after selling 343,800 shares during the period. RevolutioMay 6, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Holdings Boosted by Baker BROS. Advisors LPBaker BROS. Advisors LP raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 4.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,936,972 shares of the company's stock aMay 6, 2025 | marketbeat.comBVF Inc. IL Acquires 702,567 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)BVF Inc. IL grew its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 20.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,181,179 shares of the company's stock after purcMay 6, 2025 | marketbeat.comBellevue Group AG Cuts Position in Revolution Medicines, Inc. (NASDAQ:RVMD)Bellevue Group AG decreased its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 9.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,386,900 shares of the company's stock after selling 484,460 shares duriMay 6, 2025 | marketbeat.comBoxer Capital Management LLC Buys Shares of 4,279,464 Revolution Medicines, Inc. (NASDAQ:RVMD)Boxer Capital Management LLC purchased a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,279,464 shares of tMay 4, 2025 | marketbeat.com Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address RVMD Media Mentions By Week RVMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVMD News Sentiment▼1.060.65▲Average Medical News Sentiment RVMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVMD Articles This Week▼277▲RVMD Articles Average Week Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News ONC News TEVA News SMMT News ITCI News GMAB News RDY News VTRS News MRNA News ASND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVMD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.